Can hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer’s disease?open accessCan hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer’s disease?
- Other Titles
- Can hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer’s disease?
- Authors
- Kannappan, Balaji; te Nijenhuis, Jan; Choi, Yu Yong; Lee, Jang Jae; Choi, Kyu Yeong; Balzekas, Irena; Jung, Ho Yub; Choe, Youngshik; Song, Min Kyung; Chung, Ji Yeon; Ha, Jung-Min; Choi, Seong-Min; Kim, Hoowon; Kim, Byeong C.; Jo, Hang Joon; Lee, Kun Ho
- Issue Date
- Nov-2022
- Publisher
- Public Library of Science
- Citation
- PLoS ONE, v.17, no.11, pp.e0275233
- Journal Title
- PLoS ONE
- Volume
- 17
- Number
- 11
- Start Page
- e0275233
- URI
- http://scholarworks.bwise.kr/kbri/handle/2023.sw.kbri/182
- DOI
- 10.1371/journal.pone.0275233
- ISSN
- 1932-6203
- Abstract
- <jats:p>The diagnosis of Alzheimer’s disease (AD) needs to be improved. We investigated if hippocampal subfield volume measured by structural imaging, could supply information, so that the diagnosis of AD could be improved. In this study, subjects were classified based on clinical, neuropsychological, and amyloid positivity or negativity using PET scans. Data from 478 elderly Korean subjects grouped as cognitively unimpaired β-amyloid-negative (NC), cognitively unimpaired β-amyloid-positive (aAD), mild cognitively impaired β-amyloid-positive (pAD), mild cognitively impaired—specific variations not due to dementia β-amyloid-negative (CIND), severe cognitive impairment β-amyloid-positive (ADD+) and severe cognitive impairment β-amyloid-negative (ADD-) were used. NC and aAD groups did not show significant volume differences in any subfields. The CIND did not show significant volume differences when compared with either the NC or the aAD (except L-HATA). However, pAD showed significant volume differences in Sub, PrS, ML, Tail, GCMLDG, CA1, CA4, HATA, and CA3 when compared with the NC and aAD. The pAD group also showed significant differences in the hippocampal tail, CA1, CA4, molecular layer, granule cells/molecular layer/dentate gyrus, and CA3 when compared with the CIND group. The ADD- group had significantly larger volumes than the ADD+ group in the bilateral tail, SUB, PrS, and left ML. The results suggest that early amyloid depositions in cognitive normal stages are not accompanied by significant bilateral subfield volume atrophy. There might be intense and accelerated subfield volume atrophy in the later stages associated with the cognitive impairment in the pAD stage, which subsequently could drive the progression to AD dementia. Early subfield volume atrophy associated with the β-amyloid burden may be characterized by more symmetrical atrophy in CA regions than in other subfields. We conclude that the hippocampal subfield volumetric differences from structural imaging show promise for improving the diagnosis of Alzheimer’s disease.</jats:p>
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 연구본부 > 뇌발달질환 연구그룹 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=http://scholarworks.bwise.kr/kbri/handle/2023.sw.kbri/182)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.